NEOG - Neogen Corporation
NEXT EARNINGS:
Apr 8, 2026
EPS Est: $0.05
|
Rev Est: $204.6M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$11.00
DETAILS
HIGH:
$12.00
LOW:
$10.00
MEDIAN:
$11.00
CONSENSUS:
$11.00
DOWNSIDE:
1.96%
Market Cap:
2.44B
Volume:
1,937,631
Avg Volume:
3,872,848
52 Week Range:
3.87-11.375
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Beta:
1.98
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
2,917
IPO Date:
1989-08-23
EPS (TTM):
-5.03
P/E Ratio:
-1.16
Revenue (TTM):
894.66M
Total Assets:
3.44B
Total Debt:
912.61M
Cash & Equiv:
129.00M
Rev Growth (5Y):
16.4%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-32.5%
Debt/Equity:
0.44
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-08 | $0.10 | $0.07 | +42.9% | $224.7M | $202.6M | +10.9% |
| 2025-10-09 | $0.04 | $-0.07 | +154.1% | $209.2M | $203.1M | +3.0% |
| 2025-07-29 | $0.05 | $0.08 | -37.5% | $225.5M | $202.7M | +11.2% |
| 2025-04-09 | $0.10 | $0.13 | -23.1% | $221.0M | $222.5M | -0.7% |
| 2025-01-10 | $0.11 | $0.09 | +22.2% | $231.3M | $228.1M | +1.4% |
| 2024-10-10 | $0.07 | $0.09 | -17.6% | $217.0M | $215.0M | +0.9% |
| 2024-07-30 | $0.10 | $0.12 | -16.7% | $236.8M | $225.8M | +4.9% |
| 2024-04-09 | $0.12 | $0.14 | -14.3% | $228.8M | $235.8M | -2.9% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 894.66M | 924.22M | 822.45M | 527.16M | 468.46M | 418.17M | 414.19M | 397.93M | 361.59M | 321.27M | 283.07M | 247.41M |
| Net Income | (1.09B) | (9.42M) | (22.87M) | 48.31M | 60.88M | 59.48M | 60.18M | 63.15M | 43.79M | 36.56M | 33.53M | 28.16M |
| EPS | -5.03 | -0.04 | -0.12 | 0.45 | 0.57 | 0.57 | 0.58 | 0.61 | 0.43 | 0.36 | 0.34 | 0.29 |
| Total Assets | 3.44B | 4.55B | 4.55B | 992.93M | 920.19M | 797.18M | 695.74M | 618.01M | 528.41M | 451.71M | 392.18M | 345.30M |
| Total Debt | 912.61M | 906.24M | 897.53M | 1.44M | 1.29M | 1.05M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 129.00M | 170.61M | 163.24M | 44.47M | 75.60M | 66.27M | 41.69M | 83.07M | 77.57M | 55.26M | 66.06M | 40.67M |
| Operating Cash Flow | 58.24M | 34.73M | 41.03M | 68.04M | 81.09M | 85.88M | 63.84M | 69.13M | 60.27M | 35.33M | 43.79M | 21.67M |
| Free Cash Flow | (46.35M) | (76.69M) | (24.73M) | 43.61M | 54.38M | 61.83M | 49.18M | 48.19M | 45.70M | 21.11M | 34.17M | 10.12M |
| FCF per Share | -0.21 | -0.35 | -0.13 | 0.40 | 0.51 | 0.59 | 0.47 | 0.47 | 0.45 | 0.21 | 0.35 | 0.10 |
| Book Value | 2.07B | 3.14B | 3.13B | 887.37M | 840.38M | 725.18M | 637.90M | 560.17M | 471.76M | 404.16M | 350.96M | 306.30M |
| Cash & ST Investments | 129.00M | 170.94M | 245.57M | 381.05M | 381.09M | 343.67M | 267.52M | 210.81M | 143.63M | 107.80M | 114.16M | 76.50M |
| ROC Equity | -0.53 | -0.00 | -0.01 | 0.05 | 0.07 | 0.08 | 0.09 | 0.11 | 0.09 | 0.09 | 0.10 | 0.09 |